These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 22455739

  • 1. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia].
    Li LY, Li Q, Song LL, Jin WJ, Ma ZH, Yu YH, Zhong M.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.
    Pranpanus S, Sirichotiyakul S, Srisupundit K, Tongsong T.
    J Med Assoc Thai; 2009 Jun; 92(6):739-43. PubMed ID: 19530577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.
    Sirichotiyakul S, Maneerat J, Sa-nguansermsri T, Dhananjayanonda P, Tongsong T.
    J Obstet Gynaecol Res; 2005 Jun; 31(3):198-201. PubMed ID: 15916654
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the accuracy of the corpuscular fragility and mean corpuscular volume tests for the alpha-thalassemia 1 and beta-thalassemia traits.
    Sirichotiyakul S, Wanapirak C, Srisupundit K, Luewan S, Tongsong T.
    Int J Gynaecol Obstet; 2009 Oct; 107(1):26-9. PubMed ID: 19591999
    [Abstract] [Full Text] [Related]

  • 8. [Values of MCV,MCH,ROFT and HbA2 for Screening α-Thalassemia in Guangdong Area].
    Liu Y, Lin XY, Huang Y, Huang QW, Chen HL, Shen MN, Ruan JY, Li XY, Xu LH, Fang JP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1679-1682. PubMed ID: 33067973
    [Abstract] [Full Text] [Related]

  • 9. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
    Karimi M, Rasekhi AR.
    Haematologia (Budap); 2002 Oct; 32(2):129-33. PubMed ID: 12412732
    [Abstract] [Full Text] [Related]

  • 10. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
    Mirzakhani M, Tarrahi MJ, Baghersad A, Maracy MR.
    J Pediatr Hematol Oncol; 2019 May; 41(4):303-306. PubMed ID: 30676434
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic presentation and underlying mutations in carriers of beta-thalassaemia and alpha-thalassaemia in the Danish immigrant population.
    Kornblit B, Hagve TA, Taaning P, Birgens H.
    Scand J Clin Lab Invest; 2007 May; 67(1):97-104. PubMed ID: 17365987
    [Abstract] [Full Text] [Related]

  • 12. Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers.
    Saleh-Gohari N, Khademi Bami M, Nikbakht R, Karimi-Maleh H.
    J Clin Pathol; 2015 Jul; 68(7):562-6. PubMed ID: 25935548
    [Abstract] [Full Text] [Related]

  • 13. [The Value of Umbilical Cord Blood Erythrocyte Index in the Screening of Neonatal Thalassemia].
    Zhuang CJ, Wu XW, Wan ZD, Huang X.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):193-197. PubMed ID: 33554818
    [Abstract] [Full Text] [Related]

  • 14. Study of parents of β-thalassemia major children to determine cutoff values of hematological parameters for diagnosis of β-thalassemia trait and assessment of anemia in them.
    Bhukhanvala D, Seliya V, Shah A, Gupte S.
    Indian J Med Sci; 2013 Feb; 67(5-6):117-22. PubMed ID: 24326763
    [Abstract] [Full Text] [Related]

  • 15. Genotype and phenotype characterizations in a large cohort of β-thalassemia heterozygote with different forms of α-thalassemia in northeast Thailand.
    Yamsri S, Sanchaisuriya K, Fucharoen G, Sae-Ung N, Fucharoen S.
    Blood Cells Mol Dis; 2011 Aug 15; 47(2):120-4. PubMed ID: 21664157
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
    Gu H, Wang YX, Du MX, Xu SS, Zhou BY, Li MZ.
    Biomed Environ Sci; 2021 Aug 20; 34(8):667-671. PubMed ID: 34474730
    [Abstract] [Full Text] [Related]

  • 17. Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China.
    Zhang J, He J, Mao X, Zeng X, Chen H, Su J, Zhu B.
    BMJ Open; 2017 Jan 31; 7(1):e013367. PubMed ID: 28143837
    [Abstract] [Full Text] [Related]

  • 18. Erythrocyte Indices and Hemoglobin Analysis for α-Thalassemia Screening in an Area with High Carrying Rate.
    Zheng L, Huang H, Wu X, Shen Q, Chen M, Wang M, Su L, Xu L.
    Indian J Hematol Blood Transfus; 2022 Apr 31; 38(2):352-358. PubMed ID: 35496953
    [Abstract] [Full Text] [Related]

  • 19. Erythrocyte indices in a large cohort of β-thalassemia carrier: Implication for population screening in an area with high prevalence and heterogeneity of thalassemia.
    Singha K, Taweenan W, Fucharoen G, Fucharoen S.
    Int J Lab Hematol; 2019 Aug 31; 41(4):513-518. PubMed ID: 31099487
    [Abstract] [Full Text] [Related]

  • 20. Sensitivity and specificity of simple erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and Beta-thalassemia trait in pregnant women.
    Tongprasert F, Sirichotiyakul S, Piyamongkol W, Tongsong T.
    Gynecol Obstet Invest; 2010 Aug 31; 69(4):217-220. PubMed ID: 20068326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.